Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

aTYR Pharma INC

NASDAQ: ATYR · Life Sciences · 7 alerts · CIK 1339970

Share price
$5.24Close, Nov 16
Market cap
$13.4M
Shares outstanding
2.55MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All aTYR Pharma INC filings on SEC EDGAR ↗

9:03 AM ET 8-K
Reverse Stock Split

aTYR Pharma Reverse Stock Split

aTyr Pharma filed a Certificate of Amendment to effect a 1-for-40 reverse stock split of its common stock, effective October 28, 2026. The split will reduce the number of outstanding shares from approximately 100.5 million to 2.5 million to meet exchange requirements. Trading on a split-adjusted basis will begin on The Nasdaq Capital Market on October 29, 2026.

4:03 PM ET 8-K
Reverse Stock Split

aTYR Pharma Reverse Stock Split

aTyr Pharma stockholders approved a proposal at a special meeting to authorize the Board of Directors to effect a reverse stock split of the company's common stock. The approved ratio range is between 1-for-10 and 1-for-50, with the final ratio to be determined at the Board's discretion.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.